Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240005/S005

enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)

Bausch + Lomb, Inc. · Decision date Aug 12, 2026

FDA DECISIONP240005/S005

What did the FDA approve?

FDA records P240005/S005 as a supplement to PMA P240005, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Aug 12, 2026.

FDA approval order statement

an update to the A Constant for enVista Envy hydrophobic acrylic intraocular lens (IOL) and enVista Envy toric hydrophobic acrylic intraocular lens (IOL)
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Ophthalmic
Decision date
Aug 12, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P240005/S005
Regulatory pathway
PMA supplement
Product code
MFK
Decision code
APPR
Decision date
Aug 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P240005. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240005 · Original PMA

    enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)

  2. P240005/S003 · Related supplement

    enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)

  3. P240005/S005 received

    Application receipt date recorded by FDA.

  4. P240005/S006 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  5. P240005/S005 · FDA decision

    Special (Immediate Track)

  6. P240005/S007 · Related supplement

    enVista Envy hydrophobic acrylic intraocular lens (IOL)

  7. P240005/S008 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  8. P240005/S009 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  9. P240005/S010 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

Timeline entries are records held by MedtechLedger for P240005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240005

Explore the linked device profile

Other records with product code MFK

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA supplementOct 23, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementOct 19, 2026FDA
Rayner Intraocular Lenses , Ltd.PMA supplementSep 24, 2026FDA
Alcon Research, Ltd.PMA supplementJul 6, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1400 N. Goodman St., Rochester, NY, 14609

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records